IQ EQ FUND MANAGEMENT (IRELAND) Ltd

Position in BEAM — Beam Therapeutics Inc.

CIK 1620943 DUBLIN 2, L2

Position in BEAM

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$15,648,341

+$4,009,364 QoQ

Shares Held

455,954

-6.6% QoQ

Ownership

0.441%

of shares outstanding

% of Portfolio

1.02%

of 13F equity value

Holder Rank

#33

of 274 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $72,560,422 across 12 Biotechnology names. BEAM ranks #2 (21.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	381,991	$20,833,789
2	BEAM	Beam Therapeutics Inc. This page	455,954	$15,648,341
3	NTLA	Intellia Therapeutics, Inc.	777,948	$13,162,880
4	RXRX	Recursion Pharmaceuticals, Inc.	2,604,317	$9,557,843
5	ABSI	Absci Corp	478,520	$5,546,046
6	NRIX	Nurix Therapeutics, Inc.	89,885	$2,180,610
7	ATAI	AtaiBeckley Inc.	252,913	$1,332,851
8	IONS	Ionis Pharmaceuticals Inc	15,819	$1,254,288

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,648,341	455,954	-6.6%	Shares	Sole	2026-07-31
2026-03-31	$11,638,977	488,417	-8.5%	Shares	Sole	2026-05-11
2025-12-31	$14,790,366	533,563	+39.1%	Shares	Sole	2026-02-12
2025-09-30	$9,308,297	383,531	+96.4%	Shares	Sole	2025-11-05
2025-06-30	$3,321,848	195,288	+199.3%	Shares	Sole	2025-08-01
2025-03-31	$1,274,371	65,252	+102.7%	Shares	Sole	2025-05-09
2024-12-31	$798,510	32,198	+145.4%	Shares	Sole	2025-02-12
2024-09-30	$321,391	13,118	+41.0%	Shares	Sole	2024-10-16
2024-06-30	$217,969	9,303	—	Shares	Sole	2024-07-29
No filing history on record for this holder in this stock.